Skip to main content
Upsized offering could bring in $75M for GenMark Diagnostics

A previously announced public offering has been upsized by GenMark Diagnostics to offer about 6.4 million shares of its common stock and raise approximately $75 million in gross proceeds. The company, which has granted a 30-day option for the underwriters to buy up to 957,446 additional shares, plans to use the net proceeds for its commercialization efforts and general corporate functions.

Full Story: